Status:
SUSPENDED
A Prospective Study on The"Management of Hypertension in Young and Middle-aged Subjects in Enterprises Setting"
Lead Sponsor:
Yan Li
Conditions:
Hypertension
Blood Pressure
Eligibility:
All Genders
18-65 years
Brief Summary
In recent years, with the investment from government in the health management of the elderly, community management of hypertension in the elderly has made great progress in management rate and standar...
Eligibility Criteria
Inclusion
- Male and female sex, aged 18-65 years
- Three different daytime workplace blood pressure measurements meet the limits: systolic blood pressure ≥ 120 mmHg, or diastolic blood pressure ≥80 mmHg
- Hypertensive patients who are taking antihypertensive drugs
- Willing to provide information about disease history and lifestyle
- Willing to receive follow-up for up to 2-3 years
- Sign the informed consent
Exclusion
- Having the onset of cardiovascular and cerebrovascular diseases such as stroke, myocardial infarction or heart failure within 6 months
- Having a history of atrial fibrillation or frequent arrhythmia
- Complicating other diseases that are not suitable for the trial, such as thyroid disease with active medication, acute infectious diseases, chronic mental illness, and tumors
- The subject is participating in other clinical studies.
Key Trial Info
Start Date :
December 30 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04135911
Start Date
December 30 2019
End Date
March 31 2026
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, Shanghai Municipality, China, 200025